nach oben

Lung

Erschienen in:

04.09.2018 | ASTHMA

Annexin A5 Protein as a Potential Biomarker for the Diagnosis of Asthma

verfasst von: Sun-Hye Lee, Pureun-Haneul Lee, Byeong-Gon Kim, Jisu Hong, An-Soo Jang

Erschienen in: Lung | Ausgabe 6/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Annexin A5 (ANXA5) has a potential role in cellular signal transduction, inflammation, and fibrosis. However, the exact role of ANXA5 in asthma remains to be clarified. The aims of the present study were to investigate ANXA5 protein expression in a mouse model of asthma and pollutant exposure and to elucidate the relationships between clinical variables and plasma ANXA5 levels in patients with asthma.

Methods

A murine model of asthma induced by ovalbumin (OVA) and titanium dioxide (TiO₂) nanoparticles has been established using BALB/c mice, and we examined ANXA5 expression and lung fibrosis using this model. Moreover, we also compared ANXA5 plasma levels in patients with controlled vs. exacerbated asthma.

Results

ANXA5 protein levels were lower in lung tissue from OVA + OVA mice than in control mice. Lung ANXA5, connective tissue growth factor (CTGF), and transforming growth factor β1 (TGF-β1) protein levels were higher in OVA + TiO₂-exposed mice than in control or OVA + OVA mice. Although Dermatophagoides pteronyssinus (Derp1) treatment increased lung ANXA5 protein levels in MRC-5 cells and A549 epithelial cells, it decreased lung ANXA5 levels in NHBE cells. Treatment with TiO₂ nanoparticles increased lung ANXA5, CTGF, and TGF-β1 protein levels in MRC-5 cells, A549 epithelial cells, and NHBE cells. Plasma ANXA5 levels were lower in asthmatic patients than in healthy controls, and they were significantly enriched in patients with exacerbated asthma compared with those with controlled asthma (P < 0.05). ANXA5 levels were correlated with pulmonary function as assessed by spirometry.

Conclusion

Our results imply that ANXA5 plays a potential role in asthma pathogenesis and may be a promising marker for exacerbated bronchial asthma and exposure to air pollutants.

Global Initiative for Asthma (GINA) (2016) Global strategy for asthma management and prevention. http://ginasthma.org/wp-content/uploads/2016/04/wms-GINA-2016-main-report-final.pdf

Berair R, Brightling CE (2014) Asthma therapy and its effect on airway remodeling. Drugs 74:1345–1369CrossRef

Pavord ID, Afzalnia S, Menzies-Gow A, Heaney LG (2017) The current and future role of biomarkers in type 2 cytokine-mediated asthma management. Clin Exp Allergy 47:148–160CrossRef

Chen Z, Yoshihara E, Son A, Matsuo Y, Masutani H, Sugie K et al (2010) Differential roles of Annexin A1 (ANXA1/lipocortin-1/lipomodulin) and thioredoxin binding protein-2 (TBP 2/VDUP1/TXNIP) in glucocorticoid signaling of HTLV-I-transformed T cells. Immunol Lett 131:11–18CrossRef

Majeed M, Ernst JD, Magnusson KE, Kihlström E, Stendahl O (1994) Selective translocation of annexins III, IV, and V during intracellular redistribution of Chlamydia trachomatis serovar L2 in HeLa and McCoy cells. Ann N Y Acad Sci 730:326–328CrossRef

Monastyrskaya K, Babiychuk EB, Draeger A (2009) The annexins: spatial and temporal coordination of signaling events during cellular stress. Cell Mol Life Sci 66:2623–2642CrossRef

Tzima E, Poujol C, Nurden P, Nurden AT, Orchard MA, Walker JH (1999) Annexin V relocates to the periphery of activated platelets following thrombin activation: an ultrastructural immunohistochemical approach. Cell Biol Int 23:629–635CrossRef

Ghislat G, Aguado C, Knecht E (2012) Annexin A5 stimulates autophagy and inhibits endocytosis. J Cell Sci 125:92–107CrossRef

Rand JH, Wu XX, Lin EY, Griffel A, Gialanella P, McKitrick JC (2012) Annexin A5 binds to lipopolysaccharide and reduces its endotoxin activity. MBio 13(2):3

10.

Deng S, Wang J, Hou L, Li J, Chen G, Jing B et al (2013) Annexin A1, A2, A4 and A5 play important roles in breast cancer, pancreatic cancer and laryngeal carcinoma, alone and/or synergistically. Oncol Lett 5:107–112CrossRef

11.

Bouter A, Carmeille R, Gounou C, Bouvet F, Degrelle SA, Evain-Brion D et al (2015) Review: Annexin-A5 and cell membrane repair. Placenta 36(Suppl1):S43–S49CrossRef

12.

Luo C, Ji X, Fan J, Hou Z, Wang T, Wu B et al (2016) Annexin A5 promotes macrophage activation and contributes to pulmonary fibrosis induced by silica particles. Toxicol Ind Health 32:1628–1638CrossRef

13.

Yoshida S, Minematsu N, Chubachi S, Nakamura H, Miyazaki M, Tsuduki K et al (2012) Annexin V decreases PS-mediated macrophage efferocytosis and deteriorates elastase-induced pulmonary emphysema in mice. Am J Physiol Lung Cell Mol Physiol 303:L852–L860CrossRef

14.

Bottcher A, Gaipl US, Furnrohr BG, Herrmann M, Girkontaite I, Kalden JR et al (2006) Involvement of phosphatidylserine, alphavbeta3, CD14, CD36, and complement C1q in the phagocytosis of primary necrotic lymphocytes by macrophages. Arthritis Rheum 54:927–938CrossRef

15.

Kenis H, van Genderen H, Deckers NM, Lux PA, Hofstra L, Narula J et al (2006) Annexin A5 inhibits engulfment through internalization of PS-expressing cell membrane patches. Exp Cell Res 312:719–726CrossRef

16.

Krahling S, Callahan MK, Williamson P, Schlegel RA (1999) Exposure of phosphatidylserine is a general feature in the phagocytosis of apoptotic lymphocytes by macrophages. Cell Death Differ 6:183–189CrossRef

17.

Boersma HH, Kietselaer BL, Stolk LM, Bennaghmouch A, Hofstra L, Narula J et al (2005) Past, present, and future of annexin A5: from protein discovery to clinical applications. J Nucl Med 46:2035–2050PubMed

18.

Schutters K, Reutelingsperger C (2010) Phosphatidylserine targeting for diagnosis and treatment of human diseases. Apoptosis 15:1072–1082CrossRef

19.

Van Genderen HO, Kenis H, Hofstra L, Narula J, Reutelingsperger CP (2008) Extracellular annexin A5: functions of phosphatidylserine-binding and two-dimensional crystallization. Biochim Biophys Acta 1783:953–963CrossRef

20.

Raynal P, Pollard HB (1994) Annexins: the problem of assessing the biological role for a gene family of multifunctional calcium- and phospholipid-binding proteins. Biochim Biophys Acta 1197:63–93CrossRef

21.

Ewing MM, de Vries MR, Nordzell M, Pettersson K, de Boer HC, van Zonneveld AJ et al (2011) Annexin A5 therapy attenuates vascular inflammation and remodeling and improves endothelial function in mice. Arterioscler Thromb Vasc Biol 31:95–101CrossRef

22.

Ida M, Satoh A, Matsumoto I, Kojima-Aikawa K (2004) Human annexin V binds to sulfatide: contribution to regulation of blood coagulation. J Biochem 135:583–588CrossRef

23.

Monceau V, Belikova Y, Kratassiouk G, Charue D, Camors E, Communal C et al (2004) Externalization of endogenous annexin A5 participates in apoptosis of rat cardiomyocytes. Cardiovasc Res 64:496–506CrossRef

24.

Mirnikjoo B, Balasubramanian K, Schroit AJ (2009) Suicidal membrane repair regulates phosphatidylserine externalization during apoptosis. J Biol Chem 284:22512–22516CrossRef

25.

Narula J, Haider N, Virmani R, DiSalvo TG, Kolodgie FD, Hajjar RJ et al (1996) Apoptosis in myocytes in end-stage heart failure. N Engl J Med 335:1182–1189CrossRef

26.

Yussman MG, Toyokawa T, Odley A, Lynch RA, Wu G, Colbert MC et al (2002) Mitochondrial death protein Nix is induced in cardiac hypertrophy and triggers apoptotic cardiomyopathy. Nat Med 8:725–730CrossRef

27.

Haider N, Arbustini E, Gupta S, Liu H, Narula N, Hajjar R et al (2009) Concurrent upregulation of endogenous proapoptotic and antiapoptotic factors in failing human hearts. Nat Clin Pract Cardiovasc Med 6:250–261PubMed

28.

Tahan F, Akar HH, Saraymen B (2015) Exhaled breath condensate annexin A5 levels in exercise-induced bronchoconstriction in asthma: A preliminary study. Allergol Immunopathol (Madr) 43:538–542CrossRef

29.

Sun B, Bai Y, Zhang L, Gong L, Qi X, Li H et al (2016) Quantitative proteomic profiling the molecular signatures of Annexin A5 in lung squamous carcinoma cells. PLoS ONE 11:e0163622CrossRef

30.

Hashimoto K, Kim H, Oishi H, Chen M, Iskender I, Sakamoto J et al (2016) Annexin V homodimer protects against ischemia reperfusion-induced acute lung injury in lung transplantation. J Thorac Cardiovasc Surg 151:861–869CrossRef

31.

Buckley S, Shi W, Xu W, Frey MR, Moats R, Pardo A et al (2015) Increased alveolar soluble annexin V promotes lung inflammation and fibrosis. Eur Respir J 46:1417–1429CrossRef

32.

Schurgers LJ, Burgmaier M, Ueland T, Schutters K, Aakhus S, Hofstra L et al (2016) Circulating annexin A5 predicts mortality in patients with heart failure. J Intern Med 279:89–97CrossRef

33.

Yamaguchi M, Kokai Y, Imai S, Utsumi K, Matsumoto K, Honda H et al (2010) Investigation of annexin A5 as a biomarker for Alzheimer’s disease using neuronal cell culture and mouse model. J Neurosci Res 88:2682–2692PubMed

Titel: Annexin A5 Protein as a Potential Biomarker for the Diagnosis of Asthma
verfasst von: Sun-Hye Lee
Pureun-Haneul Lee
Byeong-Gon Kim
Jisu Hong
An-Soo Jang
Publikationsdatum: 04.09.2018
Verlag: Springer US
Erschienen in: Lung / Ausgabe 6/2018
Print ISSN: 0341-2040
Elektronische ISSN: 1432-1750
DOI: https://doi.org/10.1007/s00408-018-0159-x

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2018

Imaging Features of Chronic Bronchitis with Preserved Ratio and Impaired Spirometry (PRISm)

Prognostic Factors in Adult Patients with Non-Cystic Fibrosis Bronchiectasis

Beta 2 Adrenergic Receptor Genetic Polymorphisms in Bronchial Asthma: Relationship to Disease Risk, Severity, and Treatment Response

Electromagnetic Navigation Bronchoscopy: Where Are We Now? Five Years of a Single-Center Experience

Objective and Subjective Sleep Efficiency in Adult Patients with Cystic Fibrosis and Impact on Quality of Life

Increased Sputum IL-17A Level in Non-asthmatic Eosinophilic Bronchitis